Publication:
Increased circulating platelet aggregates in thalassaemia

dc.contributor.authorP. Winichagoonen_US
dc.contributor.authorS. Fucharoenen_US
dc.contributor.authorP. Wasien_US
dc.contributor.otherMahidol Universityen_US
dc.date.accessioned2018-10-12T07:04:31Z
dc.date.available2018-10-12T07:04:31Z
dc.date.issued1981-12-01en_US
dc.description.abstractExamination for circulating platelet aggregates according to Wu and Hoak revealed increased circulating platelet aggregates in 71% of splenectomized and 35% of nonsplenectomized patients with β°-thalassaemia/Hb E disease. This may be causally related to the newly observed high incidences of pulmonary artery thrombosis and hypoxaemia in splenectomized thalassaemic patients. It is recommended that anti-platelet aggregation drugs such as aspirin and/or dipyridamole are given to thalassaemic patients after splenectomy.en_US
dc.identifier.citationSoutheast Asian Journal of Tropical Medicine and Public Health. Vol.12, No.4 (1981), 556-560en_US
dc.identifier.issn00383619en_US
dc.identifier.other2-s2.0-0019723224en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/30215
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0019723224&origin=inwarden_US
dc.subjectMedicineen_US
dc.titleIncreased circulating platelet aggregates in thalassaemiaen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0019723224&origin=inwarden_US

Files

Collections